Newsfeeds - Spark Newswire

2 minute read

Ketamine Wellness Centers Offering FDA Approved Esketamine Treatment For Major Depressive Disorder

Today, 2:41 AM

Ketamine Wellness Centers subsidiary of Delic Holdings Corp (OTCQB: DELCF) (CSE:DELC) (FRA:6X0), has expanded its treatment options to include SPRAVATO nasal spray. The KWC clinics located in Houston, Las Vegas and Seattle will be offering this treatment option beginning April 1.

CSE:DELC

6 minute read

Psyched: MindMed’s MDMA Program For Autism, Small Pharma’s New Patent, NovaMentis’ Orphan Drug Designation

By Natan Ponieman

Today, 2:41 AM

The Week In Psychedelics: MindMed Launches MDMA Program For Social Anxiety And Autism

AWKNF

5 minute read

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai’s New Subsidiary, PharmaTher Gets New Orphan Drug Designation

By Natan Ponieman

Today, 2:41 AM

The Week In Psychedelics

AGNPF

2 minute read

There Are Now 50 Psychedelics Companies Listed In The U.S. – Here They Are

By Natan Ponieman

Today, 2:41 AM

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.

AGNPF

2 minute read

Delic Labs Applies For Dealer’s License To Work With MDMA And LSD For Medical Purposes

By Jelena Martinovic

Today, 2:41 AM

Psychedelic wellness platform Delic Holding Corp Inc. (CSE: DELC) (OTCQB: DELCF) (FRA:6X0) said Wednesday that Delic Labs has applied for a Health Canada 56 Research Exemption that would allow the scientists to perform research and tests on a host of compounds outside of psychedelic mushrooms, inclu

CSE:DELC

2 minute read

Delic Teams Up With Paradigm To Create Ketamine Toxicology Testing Solution, Raises $7M For Expansion

By Jelena Martinovic

Today, 2:41 AM

Psychedelic wellness platform Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF) (FRA:6X0) announced Thursday a first of its kind partnership with Paradigm Healthcare, an independent clinical laboratory located in St.

CSE:DELC

5 minute read

Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study

By Natan Ponieman

Today, 2:41 AM

The Week In Psychedelics:

ATAI

1 minute read

Delic Signs $10M Merger With Chain Of Ketamine Clinics

By Natan Ponieman

Today, 2:41 AM

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF), a company in the psychedelics space, has entered into a binding merger agreement with Ketamine Wellness Centers Arizona LLC, a company operating 10 ketamine infusion treatment clinics across the country.

CSE:DELC